About
Our Mission
Leadership
Partners
Our Technologies
TALEN® Technology
Gene Editing
PulseAgile Technology
Patents
Pipeline
Products
Clinical Indications
Manufacturing
Investors
Press Releases
Corporate presentation & ESG report
Scientific Presentations
Scientific Publications
Events and Webcasts
2021 Cellectis Innovation Days
Stock Information
Corporate Governance
Governance Documents
Board of Directors & Committee Members
Shareholders Meeting
SEC Filings
Contact
IR Inquiries
Email Alerts
Investor FAQ
Careers
Our Culture
Job Opportunities
Contact us
fr
Press Releases
Our latest news and press releases
Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All
2024
2023
2022
2021
2020
03
Aug 2023
12:52 E.S.T.
Cellectis Provides Business Updates and Preliminary Financial Results for Second Quarter 2023
Read more
26
Jul 2023
09:47 E.S.T.
Cellectis to Report Second Quarter 2023 Financial Results on August 3, 2023
Read more
12
Jul 2023
10:29 E.S.T.
Cellectis Appoints Dr. Cécile Chartier, Ph.D. to its Board of Directors
Read more
28
Jun 2023
10:33 E.S.T.
Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 27, 2023
Read more
08
Jun 2023
10:38 E.S.T.
Cellectis Presents Updated Clinical and Translational Data on BALLI-01 at the European Hematology Association (EHA) 2023
Read more
05
Jun 2023
12:26 E.S.T.
Cellectis Showcased Preclinical Data at an Oral Presentation and Two Poster Presentations at the 29th International Society for Cell & Gene Therapy (ISCT 2023) Annual Event
Read more
Prev
1
2
3
4
5
Next